17.42 0.00 (0.00%)
After hours: 4:17PM EDT
|Bid||17.50 x 1200|
|Ask||17.55 x 800|
|Day's Range||16.53 - 17.79|
|52 Week Range||14.12 - 25.67|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The stocks that represent the most compelling investment opportunities are the ones most poised to outperform the rest. But how are investors supposed to know which stocks have the strongest prospects for long-term growth? That’s where the TipRanks Top Analyst Stocks tool comes in. It finds all the stocks that have garnered buy ratings from the Street’s most trusted analysts. Importantly, you can organize the search results by upside potential.Stocks trading under $15 aren’t necessarily cheap. Yet, they are still quite popular among investors as they present the chance to take a larger position in a company. We used the tool to find 3 of the top-rated tech stocks under $15. Each boasts impressive upside potential and has amassed support from the best-performing analysts. Let's take a closer look: RumbleON Inc. (RMBL)The first stock on our list offers an online platform for buying and selling vehicles. The platform utilizes a capital-light network of 17 regional partnerships and is designed for dealers as well as individual customers. While RMBL is down 24% year-to-date, analysts are saying it’s undervalued at $4.08.On August 12, the company reported that its second quarter revenue reached a record high of $270 million, up from $14 million in the prior-year quarter. Not to mention its powersport sales saw 98% year-over-year growth. RMBL has made significant efforts to expand its product offering. The company added cars and trucks to RumbleOn.com and added cash offers for this segment in May 2019. It has also shifted focus towards growing RumbleOnClassifieds.com, with it now representing the third largest U.S. consumer listing site for powersports and surpassing eBay’s size in the space. Management stated that it has additional plans to add auto listings to the platform by the end of the year.Five-star B.Riley analyst Lee Krowl noted that RMBL’s shift away from less profitable inventory is an important step in the right direction. “Management indicated that they expect flat Q/Q revenue growth in 3Q with a focus on enhancing the profitability of the company driven by optimizing away from less profitable inventory,” he added. The analyst reiterated a Buy rating on RMBL stock with a $9 price target, implying 72% upside potential from current levels. (To watch Krowl's track record, click here)Five-star JMP analyst Ronald Josey cited RMBL’s expansion efforts as especially promising. On July 30, he initiated coverage on the stock with a Buy rating while setting a $10 price target, which implies nearly 150% upside. (To watch Josey's track record, click here)“Ultimately, we believe the RumbleOn platform can expand to most types of vehicles — cars, bikes, RVs, boats, ATVs — which collectively represent ~$1 trillion in annual sales across what we view as a highly fragmented industry. While it remains early days at RumbleOn, by keeping its overall days sales outstanding (DSOs) to under 30, growing consumer awareness and as its sales mix evolves to about 50/50% dealer/consumer over the next several years from its current 90/10%, we think profitability should ramp materially,” Josey explained.The rest of the Street is cautiously optimistic about RMBL. It has a ‘Moderate Buy’ analyst consensus and a $9 average price target, suggesting 108% upside. (See RMBL's price targets and analyst ratings on TipRanks) Change Healthcare Inc. (CHNG)Change Healthcare uses big data to offer revenue and payment cycle management as well as solutions for clinical information exchange, connecting payers, providers and U.S. healthcare system patients. Its products provide a more efficient and cost-effective way to transfer healthcare information. With the share price currently at $13.16, this stock looks like a steal.The healthcare-technology company, which went public in June, is already showing promising results even with the implementation of the new revenue recognition regulation, ASC 606. Following its recent Q1 earnings release, shares soared nearly 9% yesterday. It posted $856 million in sales, coming in ahead of the $796 million consensus estimate. The company also announced during the earnings release that it had been awarded a six year contract to continue providing its clinical interoperability services to CommonWell Health Alliance and introduced InterQual 2019. InterQual 2019 is its clinical decision support solution which includes a ‘Hospital in the Home' program. These programs are used as alternatives to some acute inpatient stays. With healthcare spending expected to reach $6 trillion by 2027, analysts believe CHNG looks poised to meet the demands of this ever expanding market. Five-star Piper Jaffray analyst Sean Wieland gave the stock a small boost after the company’s strong fiscal Q1 earnings release. The analyst reiterated a Buy rating and raised his price target from $18.50 to $19, suggesting 44% upside potential. “Change’s revenue and profitability came in marginally ahead of estimates after factoring out the impact of adopting ASC 606,” he explained. (To watch Wieland's track record, click here)Barclays analyst Manav Patnaik thinks CHNG has demonstrated growth prospects that go above and beyond. “We believe the company has a solid foundation to leverage its data and analytics in the growing healthcare industry,” the five-star analyst noted. The analyst rates the stock a Buy along with an $18 price target, implying 37% upside. CHNG has a ‘Strong Buy’ analyst consensus and a $19 price target, indicating 42% upside potential. (See CHNG's price targets and analyst ratings on TipRanks) Fastly Inc. (FSLY)Fastly created an innovative edge cloud computing platform that includes a content delivery network, internet security services, load balancing and video and streaming services. At $14.85, some analysts argue this tech stock is undervalued. On August 8, the company reported a second quarter revenue gain of 34% year-over-year. However, its earnings loss was wider than analysts originally expected. Despite mixed earnings results, management stated that its new product offerings could drive a turnaround. FSLY launched 60 code-based solutions that will make it safer and faster for developers to discover, test, customize and deploy edge cloud solutions. SVP of Customer Solutions, Adam Denenberg added, “Our programmable edge has always been one of the capabilities that our customers love about our platform, so we made a commitment to make it easier for developers to use all the innovative solutions our customer base is building on our edge. Providing an easy way to use prebuilt solutions on our platform was just a logical evolution to allow our customers to innovate even faster, and this launch marks another phase in our drive to empower developers around the world.”Four-star Piper Jaffray analyst James Fish believes that FSLY’s low price represents a unique buying opportunity for investors. “We believe Fastly will benefit from strong, sustainable underlying market dynamics as well as the evolutionary shift towards edge workloads,” he said. On August 14, he initiated coverage with a Buy and set a $21 price target. The Piper Jaffray analyst thinks share prices could jump 41% over the next twelve months. Stifel Nicolaus analyst Brad Reback tells investors to block out the gross margin noise. “We are still believers in Fastly's ability to drive strong net new customer additions, long-term market opportunity and relatively attractive valuation,” he explained on August 9. Reback reiterated his Buy rating and $25 price target, implying 68% upside. The five-star analyst has a 65% success rate and gets an average return of 15% per rating. The Street also takes a bullish stance on Fastly. It has a ‘Strong Buy’ analyst consensus and a $25 average price target, suggesting 65% upside potential. (See FSTL's price targets and analyst ratings on TipRanks)
Bay Area unicorn tech companies stampeded toward the IPO gate this year, making a large number of founders billionaires — in some cases more than four times over. Seven founders of the 11 Bay Area tech companies that went public this year now hold stakes worth more than $1 billion, based on the founders’ holdings on the day of the IPO, as noted in their Securities and Exchange Commission filings, as well as closing stock prices on Monday. “The one difference from 10 years ago is many of them have already sold stock through secondaries while private, so they usually have taken care of the basics like buying a home by the time they go public,” said Andy Rachleff, co-founder and CEO of online financial advising firm Wealthfront.
Cloudera is in the Activist Spotlight, as Carl Icahn seeks to speak with the board and management about enhancing shareholder value and potentially seeking board representation.
(Bloomberg) -- Shares in three of the year’s hottest IPOs, Uber Technologies Inc., Revolve Group Inc. and Fastly Inc., plunged Friday as the latest batch of newly listed companies reported some of the most disappointing results this earnings season.Uber shares ended Friday 6.8% lower after the ride-hailing company missed sales estimates. Revolve fell 15.6% after the fashion e-tailer reported earnings below expectations. And Fastly, which saw its shares dip below its IPO price intraday, declined 18.1% after reporting lighter than expected margins.The disappointment spread to other IPOs that have not even reported yet, with RealReal Inc. shares tumbling 23% to below its IPO price of $20.Call it an upset, given the hype that tends to follow IPOs. Among the nearly 20 freshly listed companies that reported earnings this week, the majority fell in the next session. IPOs are rising 0.2% on average following reports, lagging behind S&P 500 stocks, which climbed 5.3% on average, according to data compiled by Bloomberg.Other newcomers on deck to report earnings include Adaptive Biotechnologies Corp., Greenlane Holdings Inc., RealReal Inc., and Grocery Outlet Holding Inc. They are among the more well-received IPOs of this year with stocks that opened at least 40% above their offer prices. All are first-time reporters.Cross-border IPOs will be tested as well when China’s big brands So-Young International Inc. and Luckin Coffee Inc. do their show-and-tell.(Updates shares in 1st and 2nd paragraphs, adds RealReal shares in 3rd.)\--With assistance from Drew Singer.To contact the reporter on this story: Crystal Kim in New York at email@example.comTo contact the editors responsible for this story: Brad Olesen at firstname.lastname@example.org, Jennifer Bissell-Linsk, Richard RichtmyerFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
If you don't own these up-and-coming small companies in your investment portfolio yet, you could be missing out on a big opportunity for market-beating returns.
The move would allow employees and investors to sell their shares a month earlier and could potentially ring up in excess of $15 billion in sales.
The region captured a number of high-profile tech IPOs this year, some of which reached astronomical double-digit first-day gains and continue their rocket ride, while others turned to duds.
This San Francisco company not only priced its IPO $3 higher than its original pricing range but surged 76 percent on its first day.
Across the globe, 23 startups achieved unicorn status in the second quarter, of which 19 are in the U.S. Bay Area startups accounted for nearly half of all unicorns created worldwide.
The $165.2 billion exit value from IPOs and M&A; in the first half of this year has already surpassed every full year total on record, according to PitchBook Data and the National Venture Capital Association. Here are the Bay Area's 10 biggest exits in Q2.
The cloud-based enterprise software company that uses artificial intelligence to offer customer predictions and insights revealed its IPO pricing range Monday, with its valuation coming in a tad below its last funding round.
Actions speak louder than words, as the saying goes. And when it comes to insiders, that certainly seems to be the case. If we track informative insider buy transactions, we can get an idea of the stocks that insiders see as compelling investing opportunities right now. As insiders have access to a wealth of company information, these insights can be very valuable when deciding which stocks to buy or sell. With that in mind we took a closer look at three stocks insiders are snapping up right now: Immunomedics (IMMU)Immunomedics focuses on the development of antibody-drugs for the treatment of cancer. Most notably sacituzumab has received Breakthrough Therapy designation from the FDA for the treatment of patients with triple-negative breast cancer (TNBC) who failed previous therapies. It’s also granted the drug fast track designation for lung cancer treatment. Shares have surged 12% in the last five days, and that’s partly down to an influx of insider money. Most notably, corporate director and owner venBio Select Advisor LLC recently picked up a whopping $13.5 million worth of stock. That brings venBio’s total holding of IMMU to just over $298 million. And it’s not just insiders that are bullish. The stock also shows a ‘Strong Buy’ analyst consensus with an average price target of $23- indicating that further upside potential of 54% lies ahead. “As we expect sacituzumab to address a major unmet need in the treatment of r/r mTNBC [metastatic triple negative breast cancer] next year, we continue to think that IMMU is undervalued for its potential” comments Cowen & Co analyst Phil Nadeau. “We continue to expect sacituzumab will become a standard mTNBC treatment upon its approval” the analyst added. He notes that Daiichi’s DS-1062a has the potential to be long-term competition to IMMU's sacituzumab- but reassures investors that IMMU is clearly well ahead. “Given sacituzumab's several-year lead, it will be incumbent upon DS-1062a to show meaningful advantages in order to displace it” the analyst writes. Fastly Inc (FSLY)Cloud computing services provider Fastly is a newcomer to the markets. The company, which helps companies deliver online content more quickly, debuted on the NYSE back in May. Its IPO was a great success; the company sold 11.25 million shares at $16 each, bringing returns of $180 million. Since the IPO shares have surged to the current price of $20.55.And now we can see that insiders are already pouring more money into this fast-growing tech stock. Abdiel Capital Management, one of the company’s owners, has just picked up a further $7.62 million of FSLY stock. This brings the total holding to $78.8 million. No doubt this move would make sense to five-star analyst Brad Reback of Stifel Nicolaus. He initiated coverage of the stock with a buy rating and $25 price target (22% upside potential). The analyst contends: “In the coming years, we believe Fastly can leverage its superior technological approach to drive continued strong net new customer additions and expand its wallet share among its existing installed base.” Combined with a large market opportunity and the ability to further penetrate international markets, Reback is confident that Fastly can sustain at least a 30% top-line growth profile. Myovant Sciences (MYOV)Myovant Sciences is a clinical-stage biopharma developing therapies for women’s health and endocrine diseases. Shares have crashed 47% year-to-date, with the selloff prompted by the release of relugolix phase 3 uterine fibroids data. Investors are concerned about Abbvie’s (ABBV) uterine fibroid rival, Orlissa.However, insiders are demonstrating their confidence in the company. In the last three months insiders have bought a whopping $160 million of shares. That includes a $45,000 purchase from director Sebelius Kathleen, as well as $20 million from owner Viking Global Investors. Indeed, all ten transactions in the last month are positive insider buy transactions- with only one insider sell transaction recorded four months ago.Furthermore, the Street is also staying onside. All five analysts covering the stock rate Myovant a ‘buy.’ That gives the stock its ‘Strong Buy’ analyst consensus. Meanwhile their average price target of $26 indicates massive upside potential of 194%. Analysts argue that the stock looks oversold at current levels, with Barclays analyst Geoffrey Meacham saying he still believes Myovant’s relugolix has a favorable profile compared to rival offerings. Meanwhile five-star Evercore ISI analyst Ravi Mehrotra is anticipating revenues of $944M for relugolix by 2023 due to its "commercial advantage of a one-a-day pill." Discover more Hot Insider Trading Stocks here
Not only will the investors be able to start selling their shares on these dates, but so will employees of the newly minted IPO companies.
The slate of IPOs in May alone have already raked in $15 billion, marking the most raised in one month since September 2014.
Fastly Inc (NYSE: FSLY ) has a growing addressable market and is focusing on driving strong new customer additions as well as forming partnerships to support its future growth, according to Stifel. The ...
The performances of the IPOs of consumer-facing internet stocks have certainly been mixed, as shown by the disappointing debuts of Uber Technologies (NYSE:UBER) and LYFT (NASDAQ:LYFT).Source: Shutterstock The IPOs of enterprise-cloud names have been the big winners. A notable example is Zoom Video Communications (NASDAQ:ZM), which is up a sizzling 145%. In fact, on Friday there was another hot cloud IPO, Fastly (NYSE:FSLY), which soared 50%.Yet there has been one consumer internet IPO that has bucked the bearish trend: Pinterest (NYSE:PINS) IPO. But unfortunately, even this company - which operates an online scrapbooking platform -- ran into some headwinds on Friday. Following its first quarterly report as a public company, Pinterest stock plunged 13% to $26.70. But PINS stock is still up about 22% since Pinterest IPO in mid-May.InvestorPlace - Stock Market News, Stock Advice & Trading TipsNow the earnings report was fairly solid (actually, it was not too much of a surprise since PINS' registration form provided color on the quarter).So let's take a look at the quarter. Its sales jumped by 54% to $201.9 million, compared to analysts' consensus of $200.7 million. The company provided full-year, top-line guidance of $1.055 billion to $1.080 billion. Analysts, on the other hand, were looking for $1.07 billion.But the real issue - for Pinterest stock - was the bottom line. Consider that its net loss was $40 million. While that was a $7 million improvement over last year's results, the loss was a surprise for the owners of Pinterest stock. The adjusted loss was 32 cents per share of PINS stock, but analysts' average forecast was a profit of 11 cents per share.When companies are growing quickly, their expenses can pile up. Besides, as Pinterest CEO Ben Silbermann said in an interview with CNBC's Jim Cramer, the company is focused on its "long-term" outlook."And he has a point. The potential of PINS stock hinges on drivers that will take some time to get traction, such as: * International Growth: About 70% of the website's users are from outside the U.S. But its foreign revenues are still minimal, coming to only 7% of its total. And that was up from 5% in the same quarter of 2018. In other words, its overseas revenue can increase significantly. But penetrating foreign markets is far from easy. On the company's earnings call, Silbermann noted that its foreign revenue likely will not materially improve until some time next year. * Engagement: Silbermann also indicated that users generally go to Pinterest for a particular purpose and then will usually not come back. As a result, he is looking to invest in new features in an effort to boost engagement. But again, that will take time and could prove quite difficult. Just look at the struggles Twitter (NYSE:TWTR) has had with engagement. The Bottom Line on Pinterest StockThere are certainly long-term catalysts that should drive Pinterest's growth and help it reach profitability, boosting PINS stock in the process. It also helps that the company's user base jumped 22% last quarter to 291 million.The problem is that Pinterest stock already reflects much of the good news and then some. Keep in mind that PINS stock is trading at 17.5 times the company's sales. By comparison, Facebook (NASDAQ:FB) and TWTR trade at roughly nine times their sales.So Pinterest stock could drop further, especially as more shares of PINS stock come on the market when the lock-up expiration occurs in a few months. It will probably take some time for several catalysts to meaningfully boost PINS stock.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Safe Stocks to Buy for Anxious Investors * 4 Tech Stocks Looking Vulnerable * Should You Buy, Sell, Or Hold These 7 Hot IPO Stocks? Compare Brokers The post Should Investors Buy Pinterest Stock on Weakness? appeared first on InvestorPlace.